scispace - formally typeset
P

Paul N. Levett

Researcher at Saskatchewan Disease Control Laboratory

Publications -  142
Citations -  9277

Paul N. Levett is an academic researcher from Saskatchewan Disease Control Laboratory. The author has contributed to research in topics: Leptospirosis & Leptospira. The author has an hindex of 44, co-authored 137 publications receiving 8486 citations. Previous affiliations of Paul N. Levett include University of the West Indies & Centers for Disease Control and Prevention.

Papers
More filters
Book ChapterDOI

Leptospirosis in Humans

TL;DR: Data emerging from prospective surveillance studies suggest that most human leptospiral infections in endemic areas are mild or asymptomatic, and patients progressing to multisystem organ failure have widespread hematogenous dissemination of pathogens.
Journal ArticleDOI

The Leptospiral Major Outer Membrane Protein LipL32 Is a Lipoprotein Expressed during Mammalian Infection

TL;DR: The cloning of the gene encoding the 32-kDa lipoprotein, designated LipL32, the most prominent protein in the leptospiral protein profile, is reported, indicating that LipL 32 may be important in the pathogenesis, diagnosis, and prevention ofLeptospirosis.
Journal ArticleDOI

Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES

TL;DR: The findings suggest that the mutant allele of the RANTES gene contributes to the development of atopic dermatitis and its potential role in other inflammatory and infectious disorders, particularly among individuals of African ancestry, remains to be determined.
Journal ArticleDOI

Detection of pathogenic leptospires by real-time quantitative PCR.

TL;DR: A real-time PCR assay was developed using a 423 bp target on the lipL32 gene, which is conserved among pathogenic serovars of LEPTOSPIRA, which has the potential to facilitate rapid, sensitive diagnosis of acute leptospirosis.